Cited by 25Hematological disorders and diagnosticsBlood disorders and treatmentsAdvanced Biosensing Techniques and Applications

Aptamer-based proteomics of serum and plasma in acquired aplastic anemia

Open access
Giudice, Valentina, Biancotto, Angélique, Wu, Zhijie, Cheung, Foo, Candia, Julián, Fantoni, Giovanna, Kajigaya, Sachiko, Rios, Olga +3 more·2018·Experimental Hematology

Abstract

Single-stranded oligonucleotides containing deoxyuridine are aptamers (SOMAmers) that can bind proteins with high specificity and affinity and slow dissociation rates. SOMAscan, an aptamer-based proteomic technology, allows measurement of more than 1,300 proteins simultaneously for the identification of new disease biomarkers. The aim of the present study was to identify new serum and plasma protein markers for diagnosis of acquired aplastic anemia (AA) and response to immunosuppressive therapies (IST). SOMAscan was used to screen 1,141 serum proteins in 28 AA patients before and after therapy and 1,317 plasma proteins in seven SAA patients treated with standard IST and a thrombopoietin receptor agonist. From our analysis, 19 serum and 28 plasma proteins were identified as possible candidate diagnostic and prognostic markers. A custom immunobead-based multiplex assay with five selected serum proteins (BMP-10, CCL17, DKK1, HGF, and SELL) was used for validation in a verification set (n = 65) of samples obtained before and after IST and in a blinded validation cohort at baseline (n = 16). After technical validation, four biomarkers were employed to predict diagnosis (accuracy, 88%) and long-term response to IST (accuracy, 79%). In conclusion, SOMAscan is a powerful tool for the identification of new biomarkers. We propose further larger studies to validate new candidate serum and plasma diagnostic and prognostic markers of AA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.exphem.2018.09.008

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Giudice, V., Biancotto, A., Wu, Z., Cheung, F., Candia, J., Fantoni, G., Kajigaya, S., Rios, O., Townsley, D., Feng, X., & Young, N. S.
Affiliations
National Institutes of Health (US)
Corresponding author
Giudice, Valentina
Venue
Experimental Hematology
Publisher
Elsevier BV
Published
2018-12
Volume
68
Pages
38-50
ISSN
0301-472X (ISSN-L)
OpenAlex
W2896903391
Cited by
25
References
53
Citations by year
2026: 3 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 2 · 2019: 2
FWCI
3.05
Type
journal article
Language
en
Open access
Locations
  • Experimental Hematology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (Z01HL002315)
Topics
  • Health Sciences › Medicine › Emergency Medicine › Hematological disorders and diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Blood disorders and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
Keywords
acquired aplastic anemia, SomaScan, aptamer-based proteomics, serum protein biomarkers, plasma protein biomarkers, immunosuppressive therapy response, thrombopoietin receptor agonists, diagnostic biomarkers, prognostic factors, CCL17, DKK1, hepatocyte growth factor, SELL
MeSH terms
Adolescent, Adult, Aged, Anemia, Aplastic, Benzoates, Blood Proteins, Child, Child, Preschool, Female, Humans, Hydrazines, Immunosuppressive Agents, Male, Middle Aged, Pyrazoles, Biomarkers, Proteomics, Aptamers, Nucleotide, Receptors, Thrombopoietin, Young Adult, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review